Navigation Links
Lucid's VivaScope(R) Reflective Confocal Microscope Approved for Sale in China
Date:3/24/2008

ROCHESTER, N.Y., March 24 /PRNewswire/ -- China's State Food and Drug Administration has approved the sale of the pioneering Lucid VivaScope(R) reflective confocal microscope in the Peoples Republic of China, said Jay Eastman, CEO of Lucid, a Rochester, New York-based medical device and information company dedicated to providing improved care for dermatology patients.

Lucid's VivaScope(R) reflective confocal microscopes (RCM) provide non- invasive, in-vivo cellular resolution images of skin. Dermatologists can use the images to form a clinical judgment for a variety of skin conditions -- without the need for surgery to excise tissue -- thus improving the quality of care for their patients.

"Just as MRI and CT scans have largely eliminated the need for routine 'exploratory surgery', the use of Lucid's VivaScope(R) confocal microscopes may one day eliminate the need for routine invasive skin biopsies," Eastman explained.

"This milestone announcement opens opportunities for application of confocal microscopes to evaluate and monitor treatment of skin inflammatory and pigmentation disorders with leading hospitals throughout China," Eastman said.

"I am very pleased to see this positive outcome from a long and detailed review process that will allow us to participate in one of the fastest growing medical markets in the world," he said. "We believe that reflectance confocal microscopes will become a standard clinical tool with its capacity to take painless, non-invasive optical biopsies of a wide range of skin lesions and disorders."

Sales of Lucid's VivaScope(R) confocal microscopes in China will be handled by ConBio (China) Co., Ltd, Eastman said.

Dr. Qiushi Ren, CEO, ConBio said, "We are excited by the opportunity to introduce Lucid's unique, leading RCM technology to Chinese doctors and building our business together."

Founded in 1996, ConBio is a multi-specialty health care company focused on providing innovative medical devices that enable people to live life to its greatest potential. ConBio has built strategic relationships with famous manufacturers in the dermatology, plastic and ophthalmologic fields around the world, including Lucid, Cutera, RA Medical, MedArt, Lutronic, Allergan, Schwind with a goal of becoming the leading provider of the advanced medical lasers, instruments and materials in China. ConBio has successfully sold more than 1,000 units of capital equipment to customers in China and prides itself on their after-sales service.

For information, visit Lucid's website at http://www.lucid-tech.com. Contact Lucid in China at ConBio (China) Co., Ltd., by email at qren@shanghai-conbio.com or by phone at: + 86 21 62720751. In the USA, contact Lucid by email at info@lucid-tech.com, or by phone at +1-585-239-9800.

About Lucid, Inc.

Lucid, Inc. (http://www.lucid-tech.com), based in Rochester, New York (USA) is a medical device and information company with offices in North America, Europe, and Australia. Lucid is dedicated to providing improved care for dermatology patients by coupling its noninvasive VivaScope(R) cellular imaging technology with its innovative VivaNet(R) medical information system to allow secure, HIPAA compliant, near real-time collaboration between dermatologists and other medical specialists. The VivaNet(R) system provides rapid online medical image transfer, storage, and retrieval thus enabling these critical collaborative consultations. The technologies delivered by Lucid provide images that physicians use in forming critical clinical judgments in cases of dermatologic disease, while ensuring patient comfort and piece of mind.

VivaNet(R) and VivaScope(R) are registered trademarks of Lucid, Inc.
Available Topic Expert(s): For information on the listed expert(s), click appropriate link. Jay Eastman, Ph.D. http://profnet.prnewswire.com/Subscriber/ExpertProfile.aspx?ei=62055 Clifford Perlis http://profnet.prnewswire.com/Subscriber/ExpertProfile.aspx?ei=74484


'/>"/>
SOURCE Lucid, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. International Confocal Microscopy Working Group Established to Advance Practice of Reflective Confocal Microscopy
2. Nikon Instruments Launches Fully-Automated A1 Confocal Laser Microscope Series
3. Nikon Instruments New NIS-Elements C Delivers Comprehensive Confocal and Widefield Imaging Capabilities in Single Unifying Software Platform
4. Nikon Instruments Launches New Eclipse Ti-E Fully-Integrated, Motorized Inverted Microscope
5. Nikon Unveils the Eclipse Ti Inverted Microscope Series at The Society for Neroscience Annual Meeting
6. All done with mirrors: NIST microscope tracks nanoparticles in 3-D
7. Shires ELAPRASE(R) (idursulfase) Approved in Japan for the Treatment of Hunter Syndrome
8. Anesiva Outlines Comprehensive Commercialization Plan for FDA Approved Product Zingo(TM)
9. Healthcare Announced That an Overwhelming Majority of its Shareholders Approved the NexGen Biofuels Transaction
10. Bystolic(TM), a Novel Beta Blocker, is Now Approved by the FDA for the Treatment of Hypertension
11. Avastin Approved in Europe for First-Line Treatment of Patients With Advanced Kidney Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... ... 2016 , ... While the majority of commercial spectrophotometers and fluorometers use the ... models are higher end machines that use the more unconventional z-dimension of 20mm. ... the bottom of the cuvette holder. , FireflySci has developed several Agilent flow ...
(Date:6/23/2016)... 2016 /PRNewswire/ - FACIT has announced the creation ... biotechnology company, Propellon Therapeutics Inc. ("Propellon" or "the ... a portfolio of first-in-class WDR5 inhibitors for the ... WDR5 represent an exciting class of therapies, possessing ... for cancer patients. Substantial advances have been achieved ...
(Date:6/23/2016)... , June, 23, 2016  The Biodesign Challenge ... envision new ways to harness living systems and biotechnology, ... Art (MoMA) in New York City ... 130 participating students, showcased projects at MoMA,s Celeste Bartos ... Paola Antonelli , MoMA,s senior curator of architecture and ...
(Date:6/23/2016)... , June 23, 2016 Apellis ... Phase 1 clinical trials of its complement C3 ... single and multiple ascending dose studies designed to ... (PD) of subcutaneous injection in healthy adult volunteers. ... (SC) either as a single dose (ranging from ...
Breaking Biology Technology:
(Date:4/28/2016)... GOTHENBURG, Sweden , April 28, 2016 ... 1,491.2 M (139.9), up 966% compared with the first quarter of ... Operating profit totaled SEK 589.1 M (loss: 18.8) and the operating ... SEK 7.12 (loss: 0.32) Cash flow from operations was ... , The 2016 revenue guidance is unchanged, SEK 7,000-8,500 M. ...
(Date:4/15/2016)... , April 15, 2016  A new ... make more accurate underwriting decisions in a fraction ... timely, competitively priced and high-value life insurance policies ... screenings. With Force Diagnostics, rapid testing ... lifestyle data readings (blood pressure, weight, pulse, BMI, ...
(Date:3/31/2016)... BOCA RATON, Florida , March 31, 2016 /PRNewswire/ ... LEGX ) ("LegacyXChange" or the "Company") ... presentation for potential users of its soon to be ... The video ( https://www.youtube.com/channel/UCyTLBzmZogV1y2D6bDkBX5g ) will also ... by the use of DNA technology to an industry ...
Breaking Biology News(10 mins):